Chronic evolution of acute hepatitis type B: prevalence and predictive markers

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis B virus (HBV) infection is a significant global health concern.
• Understanding the long-term outcomes of acute symptomatic hepatitis B is crucial for patient management.

Purpose of the Study:

• To evaluate the outcomes of acute symptomatic hepatitis B in a prospective cohort.
• To identify risk factors and predictive markers for chronic hepatitis B and ongoing liver damage.

Main Methods:

• Prospective study of 664 adult patients with acute hepatitis B (anti-HBc IgM positive) from 1978.
• Follow-up of 443 patients for up to 12 months.
• Comparison of clinical, biochemical, and virological features between uncomplicated and complicated cases.

Main Results:

• 2.4% of infections progressed to chronic hepatitis B, with no significant difference between drug abusers and non-drug abusers.
• Ongoing liver damage post-HBsAg clearance occurred in 14% of drug abusers.
• Anicteric hepatitis, lower transaminase levels, and early positivity for HBV-DNA, DNA polymerase, and HBcAg were associated with chronic evolution.

Conclusions:

• Chronic hepatitis B is a rare complication of acute symptomatic hepatitis B.
• Drug abusers are at risk for ongoing liver damage after acute infection.
• Early detection of HBV-DNA and DNA polymerase has high predictive value for disease outcome.